What is PharmaBioServ?
PharmaBioServ operates as a specialized consulting firm focused on compliance and technology transfer services. It caters to the stringent requirements of the pharmaceutical, biotechnology, medical device, and chemical manufacturing industries across key global markets including Puerto Rico, the United States, Europe, and Brazil. The company's core offerings encompass regulatory compliance, process validation, technology transfer, engineering solutions, project management, and essential process support. Additionally, PharmaBioServ enhances industry expertise through targeted technical training and seminars, positioning itself as a critical partner for companies navigating complex regulatory landscapes.
How much funding has PharmaBioServ raised?
PharmaBioServ has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for PharmaBioServ?
The substantial enterprise-level funding PharmaBioServ has garnered, particularly the recent strategic investment, indicates a pivotal phase for the company. This capital infusion is likely earmarked for expanding its service portfolio, enhancing its technological infrastructure, and potentially broadening its geographical reach. As a key player in compliance and technology transfer, PharmaBioServ is well-positioned to capitalize on the increasing global demand for specialized consulting services within the life sciences and chemical manufacturing sectors. Future growth may involve strategic partnerships or acquisitions to further solidify its market leadership and service capabilities.
See full PharmaBioServ company page
